Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
1.09
-0.08 (-6.84%)
At close: Aug 19, 2025, 3:59 PM
1.12
2.28%
Pre-market: Aug 20, 2025, 05:54 AM EDT
-6.84% (1D)
| Bid | 1.1 |
| Market Cap | 22.71M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.54M |
| EPS (ttm) | -0.28 |
| PE Ratio (ttm) | -3.91 |
| Forward PE | -2.9 |
| Analyst | Buy |
| Ask | 1.26 |
| Volume | 631,620 |
| Avg. Volume (20D) | 5,284,209 |
| Open | 1.15 |
| Previous Close | 1.17 |
| Day's Range | 1.08 - 1.16 |
| 52-Week Range | 0.40 - 4.00 |
| Beta | 2.06 |
About KAPA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KAPA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KAPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+70.8%
Kairos Pharma shares are trading higher after the ...
Unlock content with
Pro Subscription
2 months ago
-23.47%
Kairos Pharma shares are trading lower. The company presented data on its GITR ligand agonist KROS101 at ASCO 2025.
